Your browser doesn't support javascript.
loading
Molnupiravir and Its Antiviral Activity Against COVID-19.
Tian, Lili; Pang, Zehan; Li, Maochen; Lou, Fuxing; An, Xiaoping; Zhu, Shaozhou; Song, Lihua; Tong, Yigang; Fan, Huahao; Fan, Junfen.
Afiliación
  • Tian L; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • Pang Z; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • Li M; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • Lou F; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • An X; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • Zhu S; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • Song L; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • Tong Y; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • Fan H; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • Fan J; Department of Neurology, Institute of Cerebrovascular Disease Research, Xuanwu Hospital, Capital Medical University, Beijing, China.
Front Immunol ; 13: 855496, 2022.
Article en En | MEDLINE | ID: mdl-35444647
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Coronavirus del Síndrome Respiratorio de Oriente Medio / Tratamiento Farmacológico de COVID-19 Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Coronavirus del Síndrome Respiratorio de Oriente Medio / Tratamiento Farmacológico de COVID-19 Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China